Pulmonary Fibrosis Stem Cell Therapy - Mesenchymal Stem Cell Treatment
MSC therapy for idiopathic pulmonary fibrosis (IPF) and interstitial lung disease. Reduces inflammation, promotes tissue repair, improves lung function and quality of life.
Mesenchymal stem cell therapy targeting pulmonary fibrosis progression and lung tissue regeneration.
- Idiopathic Pulmonary Fibrosis (IPF)
- Interstitial Lung Disease (ILD)
- Post-COVID Lung Fibrosis
- Occupational Lung Disease
- Anti-inflammatory and immunomodulatory effects
- Promotes alveolar tissue repair
- Improves lung function metrics
- Reduces dyspnea and cough symptoms
- Slows disease progression
肺纤维化干细胞治疗 - 间充质干细胞治疗
用于特发性肺纤维化(IPF)和间质性肺病的MSC治疗。减轻炎症、促进组织修复、改善肺功能和生活质量。
针对肺纤维化进展和肺组织再生的间充质干细胞治疗。
- 特发性肺纤维化(IPF)
- 间质性肺病(ILD)
- 新冠后肺纤维化
- 职业性肺病
- 抗炎和免疫调节作用
- 促进肺泡组织修复
- 改善肺功能指标
- 减轻呼吸困难和咳嗽症状
- 延缓疾病进展